Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Public Health dealmaking

2.1. Introduction
2.2. Public Health partnering over the years
2.3. Public Health partnering by deal type
2.4. Public Health partnering by industry sector
2.5. Public Health partnering by stage of development
2.6. Public Health partnering by technology type
2.7. Public Health partnering by therapeutic indication

Chapter 3 –Financial deal terms for Public Health partnering

3.1. Introduction
3.2. Disclosed financials terms for Public Health partnering
3.3. Public Health partnering headline values
3.4. Public Health deal upfront payments
3.5. Public Health deal milestone payments
3.6. Public Health royalty rates

Chapter 4 – Leading Public Health deals and dealmakers

4.1. Introduction
4.2. Most active in Public Health partnering
4.3. List of most active dealmakers in Public Health
4.4. Top Public Health deals by value

Chapter 5 – Public Health contract document directory

5.1. Introduction
5.2. Public Health partnering deals where contract document available

Chapter 6 – Public Health dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Public Health therapeutic target

Appendices

Appendix 1 – Directory of Public Health deals by company A-Z 2010 to 2020
Appendix 2 – Directory of Public Health deals by deal type 2010 to 2020
Appendix 3 – Directory of Public Health deals by stage of development 2010 to 2020
Appendix 4 – Directory of Public Health deals by technology type 2010 to 2020
Further reading on dealmaking
Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures

Figure 1: Public Health partnering since 2010
Figure 2: Public Health partnering by deal type since 2010
Figure 3: Public Health partnering by industry sector since 2010
Figure 4: Public Health partnering by stage of development since 2010
Figure 5: Public Health partnering by technology type since 2010
Figure 6: Public Health partnering by indication since 2010
Figure 7: Public Health deals with a headline value
Figure 8: Public Health deals with upfront payment values
Figure 9: Public Health deals with milestone payment
Figure 10: Public Health deals with royalty rates
Figure 11: Active Public Health dealmaking activity– 2010 to 2020
Figure 12: Top Public Health deals by value since 2010